Market Scope

Rodman & Renshaw has started Presbia PLC (NASDAQ: LENS) with a Buy rating and $14 price target, saying the company is "an unsung company with an intriguingly positioned device in the attractive ophthalmics domain." Presbia makes the Flexivue Microlens for presbyopia (nearsightedness). The...

Glaukos Corp (NYSE: GKOS), a glaucoma medical device maker, hopes to raise $89 million in its upcoming IPO on Thursday. Glaukos will offer 6 million shares between $16 and $17 per share. The company will list on the NYSE under the ticker GKOS. At the midpoint of the offering, Glaukos market cap...